Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus.

Date publication

septembre 2025

Journal

PloS one

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOREL Christian

Tous les auteurs :
Clatot F, Even C, Daste A, Borel C, Fayette J, Chebbah M, Le Clanche S, Saada E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40971372

Résumé

Recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) presents substantial treatment challenges due to its aggressive and heterogeneous nature. While evidence-based guidelines provide useful recommendations, they may not offer sufficient support for real-time clinical decision-making.

Mots clés

Humans, Squamous Cell Carcinoma of Head and Neck, therapy, France, epidemiology, Delphi Technique, Neoplasm Recurrence, Local, pathology, Head and Neck Neoplasms, pathology, Consensus, Clinical Decision-Making, Neoplasm Metastasis, Cetuximab, therapeutic use

Référence

PLoS One. 2025 09 19;20(9):e0332413